L'Oréal (OR) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
3 Feb, 2026Executive summary
Achieved record 2024 results with consolidated sales up 5.6% to €43.5 billion and like-for-like growth of 5.1%, outpacing the global beauty market's 4.5% growth.
Gross margin reached an all-time high of 74.2%, and operating margin hit 20% for the first time, with EPS up 4.8% to €12.66.
All divisions grew like-for-like, with standout performances in Dermatological Beauty (+9.8%) and Professional Products (+5.3%), while North Asia faced softness due to China and travel retail.
Europe and emerging markets were particularly dynamic, with significant gains, while North Asia declined due to a challenging Chinese ecosystem.
Sustainability and ESG leadership recognized with 97% renewable energy at sites, SBTi approval, and EcoVadis Platinum Medal.
Financial highlights
Gross profit rose 6% to €32.3 billion; gross margin up 30bps to 74.2%.
Operating profit increased 6.7% to €8.7 billion; operating margin up 20bps to 20%.
Net profit (excluding non-recurring items) was €6.8 billion (+4.8%); EPS reached €12.66.
Cash flow up 8.6% to €6.6 billion; operating net cash flow up 8.6%.
Dividend proposed at €7 per share (+6.1%), payout ratio 55.3%.
Outlook and guidance
Expects global beauty market growth of 4%-4.5% in 2025 and aims to outperform, with growth expected to accelerate through the year.
Focus on innovation, Beauty Stimulus Plan, and expansion in emerging markets to drive future growth.
Continued investment in R&I (3% of sales) and digital/AI-driven consumer engagement.
Committed to modest margin expansion in 2025 despite increased investment.
Latest events from L'Oréal
- Record sales, innovation, and U.S. market leadership drive strong growth and digital transformation.OR
Consumer Analyst Group of New York Conference (CAGNY) 202620 Feb 2026 - Sales up 4.0% LFL to €44.1bn, record margins, and digital growth drive strong outlook.OR
Q4 202513 Feb 2026 - H1 2024 sales and profit rose, led by Dermatological Beauty and double-digit regional growth.OR
H1 20242 Feb 2026 - A 10% stake enables strategic access to the fast-growing injectable aesthetics market.OR
M&A Announcement2 Feb 2026 - Sales up 6% to €32.4B, led by fragrances and haircare, with strong 2025 innovation plans.OR
Q3 202419 Jan 2026 - Outperformed the market in 2024, leveraging innovation, AI, and global expansion for future growth.OR
Consumer Analyst Group of New York Conference (CAGNY) 20257 Jan 2026 - Accelerating U.S. growth, market leadership, and digital innovation drive future gains.OR
CMD 20254 Dec 2025 - Luxury beauty outpaces the market with innovation, global reach, and strong brand portfolio.OR
Investor Update2 Dec 2025 - Digital, innovation, and agile strategy drive robust, accelerating growth across global beauty markets.OR
Fireside Chat2 Dec 2025